Just a moment, the page is loading...

GSK-112679




Immunogenicity and safety of GSK Biologicals’ IPV (Poliorix™) in infants
Poliomyelitis Vaccine (Inactivated)
112679
NCT01021293 2011-003167-30
Poliomyelitis
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided.
February 2015